alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.01

CERTIFICATION BY CHIEF EXECUTIVE OFFICER &
CHIEF FINANCIAL OFFICER

I, Michael Pacult, the Chief Executive Officer and Chief Financial Officer of
TriView Capital Management, Inc. as Managing Member of TriView Global Fund,
LLC, certify that (i) the Form 10K for the year ended December 31, 2006 of
TriView Global Fund, LLC fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the
information contained in the Form 10K for the year ended December 31, 2006
fairly presents, in all material respects, the financial condition and
results of operations of TriView Global Fund, LLC.


TRIVIEW GLOBAL FUND, LLC
By:  TriView Capital Management, Inc., Managing Member



By:  /s/ Michael Pacult
Michael Pacult
Chief Executive Officer &
Chief Financial Officer


Date:  March 30, 2007
Jeffrey REDDEN, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-3695

District Court of Appeal of Florida, Fifth District.

Decision filed February 13, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Exhibit 32.1 - CEO Certification

OFFICERS CERTIFICATION PURSUANT TO 906
CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBNES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Electronic Systems Technology Inc. (the "Company") on Form 10Q for the quarter ended June 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Tom L. Kirchner, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.

The Report fully complies with the requirements of section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



|                       
|-----------------------
|/s/ T. L. KIRCHNER     
|Tom L. Kirchner        
|Chief Executive Officer
|Date:  August 12, 2008
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Labor

###### Employment and Training Administration

          - [TA-W-65,566]

Pursuant to Section 221 of the Trade Act of 1974, as amended, an investigation was initiated on March 11, 2009 in response to a petition filed by the United Auto Workers Union, Local 412 on behalf of the workers of Chrysler, LLC, Chrysler Plymouth Road Office Complex, Detroit, Michigan.

The petitioner requested that the petition be withdrawn. Consequently, the investigation has been terminated.

Signed at Washington, DC, this 27th day of March 2009.

Richard Church,

Certifying Officer, Division of Trade Adjustment Assistance.

[FR Doc. E9-8937 Filed 4-17-09; 8:45 am]

BILLING CODE 4510-FN-P
Exhibit 32.2  SECTION 906 CERTIFICATION  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the quarterly report of Medizone International, Inc. (the ACompany@) on Form 10-QSB for the quarter ended March 31, 2008, as filed with the Securities and Exchange Commission on the date hereof (the AReport@), I, Steve M. Hanni, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.   /s/ Steve M. Hanni Steve M. Hanni, Principal Financial Officer  Date: July 31, 2008  A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2746 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2746

To extend and modify the temporary suspension of duty on yttrium oxide.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To extend and modify the temporary suspension of duty on yttrium oxide.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. YTTRIUM OXIDE.

    (a) In General.--Heading 9902.02.21 of the Harmonized Tariff 
Schedule of the United States (relating to yttrium oxide) is amended--
            (1) by striking ``Yttrium oxides having a purity of at 
        least 99.9 percent'' in the article description and inserting 
        ``Yttrium oxide''; and
            (2) by striking the date in the effective period column and 
        inserting ``12/31/2015''.
    (b) Effective Date.--The amendments made by subsection (a) apply to 
goods entered, or withdrawn from warehouse for consumption, on or after 
the 15th day after the date of the enactment of this Act.
                                 <all>
```
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SEC FORM
10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               MAR-31-1999
<CASH>                                           2,617
<SECURITIES>                                         0
<RECEIVABLES>                                   60,535
<ALLOWANCES>                                       106
<INVENTORY>                                          0
<CURRENT-ASSETS>                                64,673
<PP&E>                                          18,050
<DEPRECIATION>                                   9,097
<TOTAL-ASSETS>                                  98,131
<CURRENT-LIABILITIES>                           18,490
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        30,304
<OTHER-SE>                                      20,645
<TOTAL-LIABILITY-AND-EQUITY>                    98,131
<SALES>                                              0
<TOTAL-REVENUES>                                57,396
<CGS>                                                0
<TOTAL-COSTS>                                   47,987
<OTHER-EXPENSES>                                 (160)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,388
<INCOME-PRETAX>                                  8,181
<INCOME-TAX>                                     3,329
<INCOME-CONTINUING>                              4,852
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,852
<EPS-PRIMARY>                                      .72
<EPS-DILUTED>                                      .68
        

</TABLE>
II 

112TH CONGRESS 

2D SESSION S. 2602 

To suspend temporarily the duty on Buprofezin. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CARPER (for himself and Mr. COONS) introduced the following bill; which 

was read twice and referred to the Committee on Finance 

A BILL 

To suspend temporarily the duty on Buprofezin. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. BUPROFEZIN. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 (Z)-2-tert-Butylimino-3- 

isopropyl-5-phenyl-1,3,5- 

thiadiazinan-4-one 

(Buprofezin) (CAS No. 

69327–76–0 or 953030– 

84–7) (provided for in subheading 2934.99.16) ......... Free No change No change On or before 

12/31/2015 ’’. 


jbell on DSK7SPTVN1PROD with BILLS
2 

•S 2602 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
* Pursuant to 5 TH C IR . R. 47.5, the Court has determined th a t

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. UNITED STATES COURT OF APPEALS For the Fifth Circuit

No. 98-20489 Summary Calendar

JOANN BOWEN RUSSU, Plaintiff-Appellant,

VERSUS

THE CITY OF HOUSTON, TEXAS,

Defendant-Appellee.

Appeal from the United States District Court for the Southern District of Texas

(H-96-CV-3727)

February 24, 1999 Before DAVIS, DUHÉ and PARKER, Circuit Judges
PER CURIAM: *
After reviewing the record in this case and consider ing the briefs of the parties, we affirm the district court’s judgment essentially for the reasons assigned by the district court in its careful April 28, 1998 order.
AFFIRMED.
```

[Federal Register Volume 77, Number 175 (Monday, September 10, 2012)]
[Notices]
[Pages 55477-55478]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22027]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research And Quality

Special Emphasis Panel Meeting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice of SEP meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10 (a)(2) of the Federal Advisory 
Committee Act (5 U.S.C. App. 2), announcement is made of an Agency for 
Healthcare Research and Quality (AHRQ) Special Emphasis Panel (SEP) 
meeting on ``Partnerships for Sustainable Research and Dissemination of 
Evidence-Based Medicine (R24)''.

DATES: September 20-21, 2012 (Open on September 20 from 8:00 a.m. to 
8:15 a.m. and closed for the remainder of the meeting).
    This notice is being published less than 15 days prior to the 
September 20-21 meeting, due to the time constraints of reviews and 
funding cycles.

ADDRESSES: Hyatt Regency Hotel Bethesda, One Metro Center, Bethesda, MD 
20814.

FOR FURTHER INFORMATION CONTACT: Anyone wishing to obtain a roster of 
members, agenda or minutes of the non-confidential portions of this 
meeting

[[Page 55478]]

should contact: Mrs. Bonnie Campbell, Committee Management Officer, 
Office of Extramural Research, Education and Priority Populations, 
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone 
(301) 427-1554.
    Agenda items for this meeting are subject to change as priorities 
dictate.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
the Agency for Healthcare Research and Quality (AHRQ), and agree to be 
available, to conduct on an as needed basis, scientific reviews of 
applications for AHRQ support. Individual members of the Panel do not 
attend regularly-scheduled meetings and do not serve for fixed terms or 
a long period of time. Rather, they are asked to participate in 
particular review meetings which require their type of expertise.
    Substantial segments of the SEP meeting referenced above will be 
closed to the public in accordance with the provisions set forth in 5 
U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 
552b(c)(6). Grant applications for ``Partnerships for Sustainable 
Research and Dissemination of Evidence-Based Medicine (R24)'' are to be 
reviewed and discussed at this meeting. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Dated: August 30, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-22027 Filed 9-7-12; 8:45 am]
BILLING CODE 4160-90-M
```
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED MARCH 26, 2014

NO. 03

- 13

- 00685

- CR

Milton Leroy Wesley, Appellant

v.

The State of Texas, Appellee

APPEAL FROM 403RD DISTRICT COURT OF TRAVIS COUNTY

BEFORE CHIEF JUSTICE JONES, J USTICES PEMBERTON AN D ROSE

AFFIRMED

-- OPINION BY JUSTICE ROSE

This is an appeal from the trial court’s judgment of conviction . Having reviewed the record and

the parties’ arguments, the Court holds that there was no reversible error in the trial court’s

judgment of conviction . Therefore, the Court affirms the trial court’s judgment of conviction

.

Because appellant is indigent and unable to pay costs, no adjudication of costs is made.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND> 
EXHIBIT 27 - FINANCIAL DATA SCHEDULE

THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM, BALANCE
SHEET, STATEMENT OF OPERATIONS, AND STATEMENT OF CASH FLOWS AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FORM 10QSB, FOR SEPTEMBER 30, 1998.
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                       1,485,478
<SECURITIES>                                         0
<RECEIVABLES>                                  160,942
<ALLOWANCES>                                     1,284
<INVENTORY>                                    405,716
<CURRENT-ASSETS>                             2,082,364
<PP&E>                                         358,335
<DEPRECIATION>                                 238,020
<TOTAL-ASSETS>                               2,234,403
<CURRENT-LIABILITIES>                           73,248
<BONDS>                                              0
<COMMON>                                         4,954
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                   2,156,201
<TOTAL-LIABILITY-AND-EQUITY>                 2,234,403
<SALES>                                        967,678
<TOTAL-REVENUES>                             1,074,220
<CGS>                                          450,747
<TOTAL-COSTS>                                  497,303
<OTHER-EXPENSES>                               150,443
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                124,384
<INCOME-TAX>                                    42,291
<INCOME-CONTINUING>                             82,093
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    82,093
<EPS-PRIMARY>                                      .01
<EPS-DILUTED>                                      .01
        

</TABLE>
II 

112TH CONGRESS 

2D SESSION S. 2914 

To suspend temporarily the duty on certain forged steel crankshafts. 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2012 

Mr. LEVIN introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the duty on certain forged steel 

crankshafts. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CERTAIN FORGED STEEL CRANKSHAFTS. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 Forged steel crankshafts 

other than for vehicles of 

chapter 87, each measuring 

1868 mm or more in length 

and weighing 453 kg or 

more, with a stroke radius of 

95 mm or more (provided for 

in subheading 8483.10.30) ... Free No change No change On or before 

12/31/2015 ’’. 


jbell on DSK7SPTVN1PROD with BILLS
2 

•S 2914 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
**EXHIBIT
        32.1**
 
 CERTIFICATION
        PURSUANT TO
 18
        U.S.C.
        SECTION 1350, AS ADOPTED PURSUANT TO
 SECTION
        906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In
        connection with the Quarterly Report of ICF Corporation (the "Company") on
        Form
        10-QSB for the period ending September 30, 2005 as filed with the Securities
        and
        Exchange Commission on the date hereof (the "Report"), pursuant to 18 U.S.C.
§
        1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, I, Janice
        B. Fuellhart, Chief Executive Officer of the Company, certify, that to the
        best
        of my knowledge:
 
 (1)
              The
                  Report fully complies with the requirements of section 13(a) or
                  15(d) of
                  the Securities Exchange Act of 1934; and
 (2)
              The
                  information contained in the Report fairly presents, in all material
                  respects, the financial condition and results ofoperations
                  of the Company.
 
 /s/
        Janice B. Fuellhart
 
 Janice
        B.
        Fuellhart
 Chairman,
        Chief Executive Officer and President
 
 November
        21, 2005
  
 A
        SIGNED
        ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN PROVIDED
        TO
        ICF CORPORATION AND WILL BE RETAINED BY ICF CORPORATION AND FURNISHED TO
        THE
        SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST
<PAGE>
                                  EXHIBIT 11.1

                       COMPUTATION OF NET INCOME PER SHARE

<TABLE>
<CAPTION>
                                                          Three Months ended                      Nine Months ended
                                                             September 30,                          September 30,
                                                    ------------------------------          ------------------------------
                                                       2002                2001                2002                2001
                                                    ----------          ----------          ----------          ----------
<S>                                                 <C>                 <C>                 <C>                 <C>
Net income                                          $2,149,794          $1,070,415          $4,853,846          $3,882,999
                                                    ==========          ==========          ==========          ==========
Weighted average number of common
  and common equivalent shares

Weighted average common shares outstanding           2,784,813           2,698,746           2,734,464           2,698,746

Shares issued from assumed exercise of
  common stock equivalents(1)                           72,721              39,641              73,341              24,971
                                                    ----------          ----------          ----------          ----------

Weighted average number of common and
  common equivalent shares outstanding               2,857,534           2,738,387           2,807,805           2,723,717
                                                    ==========          ==========          ==========          ==========
Net income per share:
         Basic                                      $      .77          $      .40          $     1.78          $     1.44
                                                    ==========          ==========          ==========          ==========
         Diluted                                    $      .75          $      .39          $     1.73          $     1.43
                                                    ==========          ==========          ==========          ==========
</TABLE>

(1)   The number of common stock equivalents excluded from the computation of
      earnings per share because they were anti-dilutive was 37,810 for the
      three months ended September 30, 2001, and 11,007 and 74,553 for the nine
      months ended September 30, 2002 and 2001, respectively.


                                       27
---

Exhibit 18

CONSENT

The undersigned hereby consents to the use of his name and
references to, and the use of information derived from, the technical report
dated January 27, 2011 entitled Longnose and Titac Iron Titanium Exploration
Project, Minnesota, USA  Exploration Results 2010 in the following documents,
which are being filed as exhibits to and incorporated by reference into the
annual report on Form 40-F of Cardero Resource Corp. (the Company) being filed
with the United States Securities and Exchange Commission and which is being
incorporated by reference into the registration statement on Form S-8 (No.
333-151385) of the Company:

| | 1. | The Companys annual information form for the fiscal year ended
      October 31, 2010; and         
| | -- | ----------------------------------------------------------------------------------------------------
| |    |                                                                                                     
| | 2. | The Companys managements discussion and analysis for the fiscal year
      ended October 31, 2010.

DATED January 28, 2011

(signed) Stephen (Jayson) Ripke Stephen (Jayson) Ripke, QP,
MMSA

---